April 16th 2024
The 5-in-1 vaccine candidate has the potential to reduce shots and simplify the immunization process.
FDA grants emergency use authorization to Moderna’s COVID-19 booster in pediatric patients
October 13th 2022Moderna has announced that their latest BA.4/BA.5 Omicron-targeting bivalent COVID-19 booster vaccine, mRNA-1273.222, has been granted Emergency Use Authorization by the US Food and Drug Administration.